Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-11-26 | Dr. Dolev Rafaeli was appointed the Company's Interim Chief Executive Officer effective April 10, 2018 and became the Company's Chief Executive Officer effective on May 29, 2018. Dr. Rafaeli has over 25 years of experience in the healthcare, medical device, consumer and industrial services fields. |
| 2019-11-27 | Dr. Dolev Rafaeli was appointed the Companys Interim Chief Executive Officer effective April 10, 2018 and became the Companys Chief Executive Officer effective on May 29, 2018. ... The following table sets forth the compensation earned by our principal executive officers and other executive officers during our last two completed fiscal years; such officers are referred to herein as the named executive officers: Dolev Rafaeli, Director, President and Chief Executive Officer 2018 Total ($) 2,692,066. |
| 2020-11-27 | Dr. Dolev Rafaeli, Director, President and Chief Executive Officer ... Total compensation $1,167,630. |
| 2024-09-26 | Dr. Dolev Rafaeli (age 60) assumed the duties of President, Chief Executive Officer, and Vice-Chairman of the Board in October 2023. ... No director compensation listed for Dr. Rafaeli in the director compensation table. |
Data sourced from SEC filings. Last updated: 2026-03-05